Kate L. Millington, MD

Adjunct Instructor, Pediatrics

Kate Millington


Kate Millington, MD, is a pediatric endocrinologist with specific clinical and research interest in reproductive endocrinology, including disorders of puberty, transgender health, and differences in sex development.

Dr. Millington earned her medical degree at the Perelman School of Medicine at the University of Pennsylvania. She completed residency in pediatrics and fellowship in pediatric endocrinology at Boston Children’s Hospital.

Other Positions

  • Boston Children's Hospital


  • University of Pennsylvania School of Medicine, MD
  • Columbia University School of Engineering, BS
  • Bard College at Simon's Rock, BA


  • Published on 7/7/2022

    Kempf AM, Burns ZT, Guss CE, Millington K, Pilcher S, Boyle PJ, Charlton BM, Haas-Kogan DA, Liu KX. Clinical outcomes and considerations of gender-affirming care for transgender and gender-diverse pediatric and young adult patients with cancer. Pediatr Blood Cancer. 2023 Jan; 70(1):e29851. PMID: 35713118.

    Read at: PubMed
  • Published on 3/10/2022

    Krebs D, Harris RM, Steinbaum A, Pilcher S, Guss C, Kremen J, Roberts SA, Baskaran C, Carswell J, Millington K. Care for Transgender Young People. Horm Res Paediatr. 2022; 95(5):405-414. PMID: 35272283.

    Read at: PubMed
  • Published on 3/1/2022

    Barrera E, Millington K, Kremen J. The Medical Implications of Banning Transgender Youth From Sport Participation. JAMA Pediatr. 2022 03 01; 176(3):223-224. PMID: 34870701.

    Read at: PubMed
  • Published on 1/26/2022

    Millington K, Barrera E, Daga A, Mann N, Olson-Kennedy J, Garofalo R, Rosenthal SM, Chan YM. The effect of gender-affirming hormone treatment on serum creatinine in transgender and gender-diverse youth: implications for estimating GFR. Pediatr Nephrol. 2022 Sep; 37(9):2141-2150. PMID: 35083530.

    Read at: PubMed
  • Published on 12/21/2021

    Pollock NI, Flamand Y, Zhu J, Millington K, Stevenson K, Silverman LB, Vrooman LM, Cohen LE. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration. Pediatr Blood Cancer. 2022 07; 69(7):e29505. PMID: 34931744.

    Read at: PubMed
  • Published on 12/1/2021

    Tremblay ES, Millington K, Monuteaux MC, Bachur RG, Wolfsdorf JI. Plasma ß-Hydroxybutyrate for the Diagnosis of Diabetic Ketoacidosis in the Emergency Department. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1345-e1350. PMID: 32011560.

    Read at: PubMed
  • Published on 10/27/2021

    Aamodt K, Fitzgerald SL, Hanono A, Majzoub J, Millington K, Richmond TK, Peeler KR. Severe Hypernatremia in an Adolescent With Anorexia Nervosa. Clin Pediatr (Phila). 2021 12; 60(14):586-590. PMID: 34706583.

    Read at: PubMed
  • Published on 10/2/2021

    Millington K, Chan YM. Lipoprotein subtypes after testosterone therapy in transmasculine adolescents. J Clin Lipidol. 2021 Nov-Dec; 15(6):840-844. PMID: 34657833.

    Read at: PubMed
  • Published on 7/24/2021

    Schulmeister C, Millington K, Kaufman M, Finlayson C, Kennedy JO, Garofalo R, Chan YM, Rosenthal SM. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists. J Adolesc Health. 2022 01; 70(1):108-113. PMID: 34315674.

    Read at: PubMed
  • Published on 5/1/2021

    Kremen J, Williams C, Barrera EP, Harris RM, McGregor K, Millington K, Guss C, Pilcher S, Tishelman AC, Baskaran C, Carswell J, Roberts S. Addressing Legislation That Restricts Access to Care for Transgender Youth. Pediatrics. 2021 05; 147(5). PMID: 33883246.

    Read at: PubMed

View 8 more publications: View full profile at BUMC

View all profiles